Last month, a Pennsylvania woman and her Fosamax femur lawyer filed a lawsuit against Merck Sharp & Dohme Corp., alleging that her spontaneous leg break was caused by a generic version of the osteoporosis drug Fosamax.
In a product liability suit filed on March 7 in the U.S. District Court of New Jersey, Theresa Metz alleges that generic Fosamax manufactured by Merck & Co. subsidiary Merck Sharp & Dohme Corp. caused her femur to fracture while she was walking down a sidewalk. Metz was subsequently hospitalized and had two titanium rods inserted into her thigh bone. You can go through http://www.taxoterehairlawsuit.com/ to get details about hair loss lawsuit.
And due to respiratory failure during surgery, she additionally required placement in an intensive care unit and a blood transfusion. Upon recovery Metz received physical therapy and home health care and currently needs a cane to walk. As a result of her injuries, the plaintiff is seeking compensatory and punitive damages, accusing Merck of defective product design and failing to warn of Fosamax's side effects.
The allegation by Metz that her leg broke while she was walking is consistent with those made in a growing number of femur fracture lawsuits against Merck. Around 100 people have sued the pharmaceutical company to date, claiming that Fosamax caused them to suffer so-called "low energy" fractures that occur when a person falls from a standing height or less.